ADVERTISEMENT RETURN TO ISSUEEditorialNEXTVirtual Issue on Nanomaterials for Drug DeliveryPaula T. HammondCite this: ACS Nano 2011, 5, 2, 681–684Publication Date (Web):February 22, 2011Publication History Published online22 February 2011Published inissue 22 February 2011https://pubs.acs.org/doi/10.1021/nn2003508https://doi.org/10.1021/nn2003508editorialACS PublicationsCopyright © 2011 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views4028Altmetric-Citations19LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (2 MB) Get e-AlertscloseSUBJECTS:Drug delivery,Molecules,Nanomaterials,Nanoparticles,Targeting Get e-Alerts
No takes yet. Share an insight, caveat, or question.
Paula T. Hammond (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: